Wang, Shih-Chung <br/><br/>
Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.  [electronic resource] 

 -  Pediatric blood & cancer  02 2020 
 - e28075 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.28075  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Case-Control Studies<br/>Child<br/>Child, Preschool<br/>Cytokines--metabolism<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunity, Innate--drug effects<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Lymphocytes--drug effects<br/>Male<br/>Prognosis<br/>Prospective Studies<br/>Purpura, Thrombocytopenic, Idiopathic--drug therapy<br/>T-Lymphocytes, Regulatory--drug effects